Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Else Nutrition Holdings ( (TSE:BABY) ) just unveiled an announcement.
Else Nutrition Holdings said the Toronto Stock Exchange will delist its common shares and warrants at the close of trading on May 8, 2026, after the exchange concluded the company no longer meets its continued listing requirements. The company is weighing a further review of the decision and exploring an immediate move to an alternative Canadian exchange, while maintaining normal operations, rebuilding inventory to meet rising demand, and continuing substantive FDA interactions on its infant formula approval.
Management stressed that despite the impending delisting, business activities are ongoing as the company works to align its capital markets presence with its growth trajectory in the plant-based pediatric nutrition segment. The outcome of the listing review, alternate exchange strategy, and FDA approval efforts could materially affect Else Nutrition’s access to capital, market visibility, and long-term competitive positioning in the specialized formula and dairy-alternative market.
The most recent analyst rating on (TSE:BABY) stock is a Hold with a C$0.04 price target. To see the full list of analyst forecasts on Else Nutrition Holdings stock, see the TSE:BABY Stock Forecast page.
Spark’s Take on BABY Stock
According to Spark, TipRanks’ AI Analyst, BABY is a Neutral.
The score is weighed down primarily by weak financial performance (shrinking revenue, deeply negative margins, negative equity, and ongoing cash burn). Technicals add further pressure with a clear downtrend and negative momentum. Valuation provides limited support because losses make the P/E uninformative and there is no dividend yield data.
To see Spark’s full report on BABY stock, click here.
More about Else Nutrition Holdings
Else Nutrition Holdings Inc. is a food and nutrition company in an international expansion phase, focused on innovative, clean, plant-based products for infants, toddlers, children, and adults. Its flagship non-soy, plant-based formula offers a clean-ingredient alternative to dairy-based formulas and has gained national retail support, strong Amazon rankings, and multiple industry awards for dairy alternatives and baby nutrition products.
Average Trading Volume: 108,782
Technical Sentiment Signal: Sell
Current Market Cap: C$1.68M
For an in-depth examination of BABY stock, go to TipRanks’ Overview page.